Loading, please wait...
Date: Nov 19, 2021 02:00 PM - 02:45 PM
Location: UIW Feik School of Pharmacy, 703 E. Hildebrand, San Antonio, TX, 78212
CE Hours
1.00
CE Units
0.100
Registration closes on Dec 31, 2021 11:55 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
The University of the Incarnate Word Feik School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
- The participant will only receive credit for programs after receiving a 70% on a post-test and an evaluation form is completed and submitted.
- The entire session must be attended to receive credit. No partial credit will be given.
- Certificates will not be mailed. Contact hours will be uploaded to NABP's CPE Monitor after successful completion of post-test and program evaluation.
- To receive credit, participant profiles must contain a valid NABP e-profile ID number and month/date of birth.
- All requirements to receive credit must be completed within six weeks of participation in the CPE program. Failure to complete requirements within the six-week window will result in no credit awarded to the participant.
Registration closes on Dec 31, 2021
at 11:55 PM
Registration closes on Dec 31, 2021
at 11:55 PM
Registration Closed
Registration Closed
Upon completion of this activity, pharmacists will be able to:
- Describe the shared pathophysiology of chronic kidney disease (CKD) and heart failure (HF).
- Discuss the cardiovascular and renal benefits of SGLT-2 inhibition in CKD and HF.
- Summarize the effects of SGLT-2 inhibitors on mortality, heart failure hospitalizations, and renal outcomes in patients with CKD and HF.
Speaker(s)/Author(s)
|
Haley Tierce |
Activity Number
0445-0000-21-017-L01-P
Date:
11/19/21
Time:
02:00 PM - 02:45 PM
CE Hours
1.00
Location
https://teams.microsoft.com/l/meetup-join/19%3amee
Registration Closed